We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
ACV Auctions
ACVA
$1.3B
| $57.4M | 0.07% |
2,657,402
-77,653
| -3% | -$1.57M |
|
102
Churchill Downs
CHDN
$6.12B
| $57.1M | 0.07% |
427,666
-548
| -0.1% | -$75.9K |
|
103
ESCO Technologies
ESE
$7.92B
| $56.8M | 0.07% |
426,085
-12,451
| -3% | -$1.69M |
|
104
Applied Industrial Technologies
AIT
$13.3B
| $56.7M | 0.07% |
236,799
-6,918
| -3% | -$1.72M |
|
105
Piper Sandler
PIPR
$5.29B
| $56.5M | 0.07% |
753,900
-22,032
| -3% | -$1.71M |
|
106
BellRing Brands
BRBR
$1.34B
| $56M | 0.07% |
743,014
-64,745
| -8% | -$4.6M |
|
107
Vericel Corp
VCEL
$2.31B
| $55.5M | 0.07% |
1,010,546
-29,524
| -3% | -$1.49M |
|
108
Cactus
WHD
$5.44B
| $55.2M | 0.07% |
945,043
-27,611
| -3% | -$1.73M |
|
109
Grid Dynamics Holdings
GDYN
$615M
| $55.1M | 0.07% |
+2,478,115
| New | +$43.3M |
|
110
Oceaneering
OII
$4.77B
| $54.9M | 0.07% |
2,106,002
+267,230
| +15% | +$7.07M |
|
111
ITT
ITT
$19.1B
| $54.5M | 0.07% |
381,167
-413
| -0.1% | -$61.8K |
|
112
Varonis Systems
VRNS
$5B
| $54.3M | 0.07% |
1,221,877
-35,703
| -3% | -$1.86M |
|
113
SiteOne Landscape Supply
SITE
$4.53B
| $54M | 0.07% |
410,062
-12,311
| -3% | -$1.78M |
|
114
WEX
WEX
$6.31B
| $53.8M | 0.07% |
306,911
-1,154
| -0.4% | -$216K |
|
115
Veeva Systems
VEEV
$37.4B
| $53.8M | 0.07% |
255,674
-15,450
| -6% | -$3.4M |
|
116
Supernus Pharmaceuticals
SUPN
$2.77B
| $53M | 0.07% |
1,467,027
-49,096
| -3% | -$1.73M |
|
117
Vita Coco
COCO
$3.6B
| $52.5M | 0.07% |
1,421,999
+193,420
| +16% | +$6.44M |
|
118
Colliers International
CIGI
$5.19B
| $51.3M | 0.06% |
377,001
+18,253
| +5% | +$2.7M |
|
119
Itron
ITRI
$4.54B
| $51.1M | 0.06% |
471,026
-72,859
| -13% | -$8.14M |
|
|
VRNA
120
DELISTED
Verona Pharma
VRNA
| $50.1M | 0.06% |
1,079,555
-31,541
| -3% | -$1.18M |
|
|
SKX
121
DELISTED
Skechers
SKX
| $49.3M | 0.06% |
733,678
-18,389
| -2% | -$1.19M |
|
122
AAR Corp
AIR
$5.76B
| $48.5M | 0.06% |
791,314
+1,047
| +0.1% | +$67.1K |
|
|
CYBR
123
DELISTED
CyberArk
CYBR
| $48.1M | 0.06% |
144,339
-15,807
| -10% | -$4.8M |
|
124
Boot Barn
BOOT
$4.95B
| $47.7M | 0.06% |
314,197
-152,028
| -33% | -$22.5M |
|
125
Moog Inc Class A
MOG.A
$12.8B
| $46.5M | 0.06% |
236,041
-15,449
| -6% | -$3.17M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.